New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Gossamer Bio, Inc.
GOSS
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

219M

Biotechnology

Next Earning date - 14 Nov 2024

219M

Biotechnology

Next Earning date - 14 Nov 2024

0.97USD
Shape-0.00 ( -0.14%)
Market Open
favorite-chart

Relative Strenght

6
favorite-chart

Volume Buzz

-98%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

40%

Quote Panel

Shape
Updated October 16, 2024
1W -2.40 % 1M 6.83 % 3M -11.92 % 1Y 50.25 %

Key Metrics

Shape
  • Market Cap

    218.69M


  • Shares Outstanding

    226.23M


  • Share in Float

    186.86M


  • Dividende

    0


  • Earning Date

    14 Nov 2024


  • Price Target

    0.9667


  • Average Volume

    942206


  • Beta

    1.964


  • Range

    0.453-1.6


  • Industry

    Biotechnology


  • Website

    https://www.gossamerbio.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

2.13x

P/S Ratio

2.69x

P/B Ratio

2.4

Debt/Equity

-78.8%

Net Margin

$-0.2

EPS

How GOSS compares to sector?

P/E Ratio

Relative Strength

Shape

GOSS

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$19M

Shape-81%

2025-Revenue

$0.71

Shape-424%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Oppenheimer

initialise

Previous: Buy

2024-06-24

Now: Outperform

Guggenheim

initialise

Previous: Not converted

2024-05-06

Now: Positive

Raymond James

downgrade

Previous: Outperform

2023-03-07

Now: Market Perform

Barclays

downgrade

Previous: Overweight

2022-12-07

Now: Equal-Weight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.65
vs -0.80

Q4.22

arrow
arrow

N/A

-0.59
vs -0.74

Q1.23

arrow
arrow

N/A

-0.52
vs -0.76

Q2.23

arrow
arrow

N/A

-0.45
vs -0.74

Q3.23

arrow
arrow

N/A

-0.21
vs -0.65

Q4.23

arrow
arrow

N/A

-0.21
vs -0.59

Q1.24

arrow
arrow

N/A

-0.19
vs -0.52

Q2.24

arrow
arrow

+149%

0.22
vs -0.45

Q3.24

arrow
arrow

N/A

-0.15
vs -0.21

Q4.24

arrow
arrow

N/A

-0.15
vs -0.21

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

6.8M  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

95.8M  vs NA

Q3.24

arrow
arrow

NA

8.5M  vs NA

Q4.24

arrow
arrow

+26%

8.5M  vs 6.8M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-111%

-1.11
vs 3.59

Q4.22

arrow
arrow

+6%

0.06
vs -1.11

Q1.23

arrow
arrow

+5%

0.05
vs 0.06

Q2.23

arrow
arrow

+68%

0.68
vs 0.05

Q3.23

arrow
arrow

-38%

-0.38
vs 0.68

Q4.23

arrow
arrow

-77%

-0.77
vs -0.38

Q1.24

arrow
arrow

-157%

-1.57
vs -0.77

Q2.24

arrow
arrow

+60%

0.6
vs -1.57

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

179

179
vs 142

26%

Q4.22

arrow
arrow

126

126
vs 179

-30%

Q1.23

arrow
arrow

113

113
vs 126

-10%

Q2.23

arrow
arrow

103

103
vs 113

-9%

Q3.23

arrow
arrow

98

98
vs 103

-5%

Q4.23

arrow
arrow

102

102
vs 98

4%

Q1.24

arrow
arrow

113

113
vs 102

11%

Q2.24

arrow
arrow

100

100
vs 113

-11%

Earnings Growth

Latest News

GOSS

247wallst.com

7 hours ago